Revision as of 07:50, 2 January 2025 editIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers34,291 editsm clean up, added orphan tagTag: AWB← Previous edit | Latest revision as of 00:47, 3 January 2025 edit undoGraeme Bartlett (talk | contribs)Administrators249,851 edits chemspider | ||
Line 81: | Line 81: | ||
| IUPHAR_ligand = | | IUPHAR_ligand = | ||
| DrugBank = | | DrugBank = | ||
| ChemSpiderID = | | ChemSpiderID = 128992995 | ||
| UNII = AYFFM7L5F0 | | UNII = AYFFM7L5F0 | ||
| KEGG = | | KEGG = |
Latest revision as of 00:47, 3 January 2025
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (January 2025) |
Pharmaceutical compound
Clinical data | |
---|---|
Other names | D-0120 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C18H16N2O2S |
Molar mass | 324.40 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Darbinurad is a investigational new drug that is being evaluated for the treatment of gout. It is a selective urate transporter 1 (URAT1) inhibitor that blocks the reabsorption of uric acid within the renal proximal tubule, thereby reducing serum uric acid concentrations.
References
- Kaufmann D, Chaiyakunapruk N, Schlesinger N (November 2024). "Optimizing gout treatment: A comprehensive review of current and emerging uricosurics". Joint Bone Spine. 92 (2): 105826. doi:10.1016/j.jbspin.2024.105826. PMID 39622367.
- "Darbinurad". PatSnap.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |